Navigation Links
2009 Signature Genomic Laboratories Travel Award winner announced
Date:3/31/2009

Kathy M. Chun, PhD, FACMG was honored as the 2009 recipient of the Signature Genomic Laboratories Travel Award at the American College of Medical Genetics (ACMG) 2009 Annual Clinical Genetics Meeting in Tampa, Florida. Dr. Chun is Director, Cytogenetics and Molecular Genetics at the North York General Hospital in Toronto, Canada. Dr. Chun received her PhD from the University of Toronto in Biochemistry.

A new award in 2008, the Signature Genomics Travel Award is given to a selected student, trainee or junior faculty ACMG member whose abstract submission was chosen as a platform presentation during the ACMG Annual Clinical Genetics Meeting. The ACMG program committee selects the Travel Award recipient based on scientific merit. In recognition of the selected presentation, Signature Genomics covers the travel costs for the recipient to the ACMG meeting.

"The American College of Medical Genetics Foundation is grateful to Signature Genomics for their generous support of up-and-coming medical genetic researchers through the Signature Genomics Travel Award," said R. Rodney Howell, MD, FACMG, president of the ACMGF.

"Signature supports the recognition of outstanding young researchers in the field of medical genetics, "said Lisa G. Shaffer, PhD, president and CEO of Signature Genomics. "We are proud to be sponsoring this award."


'/>"/>

Contact: Kathy Ridgely Beal
kbeal@acmg.net
301-238-4582
American College of Medical Genetics
Source:Eurekalert

Page: 1

Related biology news :

1. CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda
2. Stroma genomic signature predicts resistance to anthracyclin-based chemotherapy in breast cancer
3. CIC to Host Webinar Featuring Independent Research Firm: Enabling Straight Through Processing - Why the Insurance Industry Needs Electronic Signature Technology
4. Scientists make strides toward defining genetic signature of Alzheimers disease
5. CIC Teams With Industry Leader iPipeline to Provide Electronic Signature Platform to the Nations Top Insurance Carriers
6. Cancer signatures uncovered
7. Dartmouth researchers discover gene signatures for scleroderma
8. 2008 Signature Genomic Laboratories Travel Award presented
9. Genes selective signature aids detection of natural selection in microbial evolution
10. Entrust Digital Signatures Help Secure More Than 18 Million U.S. ePassports
11. Cancer Genomics Browser gives cancer researchers a powerful new tool
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... Lawrence, MA (PRWEB) , ... June 23, 2016 ... ... the Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research ... test platform of microbial tests introduced last year,” stated Bob Salter, Vice President ...
Breaking Biology Technology: